Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Jonna M. Leyrer-Jackson, Amanda M. Acuña & M. Foster Olive. (2022) Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update. Expert Opinion on Pharmacotherapy 23:16, pages 1819-1830.
Read now
Read now
Ekaterina Pivovarova, Hye Sung Min & Peter D. Friedmann. (2021) Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Substance Abuse 42:4, pages 618-624.
Read now
Read now
Brendan Saloner, Barbara Andraka Christou, Adam J. Gordon & Bradley D. Stein. (2021) It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver. Substance Abuse 42:2, pages 153-157.
Read now
Read now
Gerald Cochran, Julie Bruneau, Nicholas Cox & Adam J. Gordon. (2020) Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse 41:3, pages 269-274.
Read now
Read now
Adam J. Gordon, Karen Drexler, Eric J. Hawkins, Jennifer Burden, Nodira K. Codell, Amy Mhatre-Owens, Matthew T. Dungan & Hildi Hagedorn. (2020) Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse 41:3, pages 275-282.
Read now
Read now
Florence Vorspan, Peter Hjelmström, Nicolas Simon, Amine Benyamina, Alain Dervaux, Georges Brousse, Thierry Jamain, Margaux Kosim & Benjamin Rolland. (2019) What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine. Expert Opinion on Drug Delivery 16:9, pages 907-914.
Read now
Read now
Laura B. Monico, Jan Gryczynski, Robert P. Schwartz, Jerome H. Jaffe, Kevin E. O’Grady & Shannon Gwin Mitchell. (2018) Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months. The American Journal of Drug and Alcohol Abuse 44:6, pages 604-610.
Read now
Read now
Karen McElrath. (2018) Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary. Substance Use & Misuse 53:2, pages 334-343.
Read now
Read now
Stéphanie Bourion-Bédès, Raymund Schwan, Paolo Di Patrizio, Guillaume Vlamynck, Sarah Viennet, Maxime Schvartz, Anne Gaunard, Alex Bédès, Isabelle Clerc-Urmès & Cédric Baumann. (2017) The effects of patient and physician characteristics on early outpatient satisfaction with substance dependence care: results of the SUBUSQOL study. Patient Preference and Adherence 11, pages 887-896.
Read now
Read now
Daniel P. Riggins, Chinazo O. Cunningham, Yuming Ning & Aaron D. Fox. (2017) Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients. Substance Abuse 38:3, pages 297-302.
Read now
Read now
Shannon Gwin Mitchell, Jan Gryczynski, Robert P. Schwartz, C. Patrick Myers, Kevin E. O’Grady, Yngvild K. Olsen & Jerome H. Jaffe. (2015) Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. Journal of Psychoactive Drugs 47:2, pages 149-157.
Read now
Read now
Cheryl Teruya, Robert P. Schwartz$suffix/text()$suffix/text(), Shannon Gwin Mitchell, Albert L. Hasson$suffix/text()$suffix/text(), Christie Thomas, Samantha H. Buoncristiani$suffix/text()$suffix/text(), Yih-Ing Hser, Katharina Wiest, Allan J. Cohen, Naomi Glick, Petra Jacobs, Paul McLaughlin & Walter Ling. (2014) Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. Journal of Psychoactive Drugs 46:5, pages 412-426.
Read now
Read now
Yinghua Xia, Di Zhang, Xiaoming Li, Wen Chen, Qun He, Heiko
J. Jahn, Xin Li, Jun Chen, Pei Hu & Li Ling. (2013) Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: A qualitative study in South China. Psychology, Health & Medicine 18:3, pages 321-329.
Read now
Read now
Qun He, Xiaorong Wang, Yinghua Xia, Jeffrey S. Mandel, Ang Chen, Lili Zhao, Lu Han & Li Ling. (2011) New Community-Based Methadone Maintenance Treatment Programs in Guangdong, China, and Their Impact on Patient Quality of Life. Substance Use & Misuse 46:6, pages 749-757.
Read now
Read now
A. Karow, U. Verthein, R. Pukrop, J. Reimer, C. Haasen, M. Krausz & I. Schäfer. (2011) Quality of Life Profiles and Changes in the Course of Maintenance Treatment Among 1,015 Patients With Severe Opioid Dependence. Substance Use & Misuse 46:6, pages 705-715.
Read now
Read now
Sabine Loeber, Anja Kniest, Alexander Diehl, Karl Mann & Bernhard Croissant. (2008) Neuropsychological Functioning of Opiate-Dependent Patients: A Nonrandomized Comparison of Patients Preferring either Buprenorphine or Methadone Maintenance Treatment. The American Journal of Drug and Alcohol Abuse 34:5, pages 584-593.
Read now
Read now
Articles from other publishers (57)
Anh Dam Tran, Jason Grebely, Mark Chambers, Louisa Degenhardt, Michael Farrell, Sahar Bajis & Briony Larance. (2024) Health utility among people who regularly use opioids in Australia. Drug and Alcohol Review 43:4, pages 997-1012.
Crossref
Crossref
Hannah B Apsley, Kristina Brant, Sarah Brothers, Eric Harrison, Emma Skogseth, Robert P Schwartz & Abenaa A Jones. (2024) Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them. Women's Health 20.
Crossref
Crossref
Emily Pasman, Sydney O'Shay, Suzanne Brown, Erin Fanning Madden, Elizabeth Agius & Stella M. Resko. (2023) Ambivalence and contingencies: A qualitative examination of peer recovery coaches' attitudes toward medications for opioid use disorder. Journal of Substance Use and Addiction Treatment 155, pages 209121.
Crossref
Crossref
Hu‐Ming Chang, Ming‐Chyi Huang, Su‐Chen Fang & Shih‐Ku Lin. (2023) Quality of life and associated factors of heroin‐dependent patients receiving methadone and buprenorphine maintenance treatment. Neuropsychopharmacology Reports 43:4, pages 607-615.
Crossref
Crossref
Daniel Rutrick, Susan M. Learned, Brent Boyett, David Hassman, Sunita Shinde & Yue Zhao. (2023) 18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies. Journal of Substance Use and Addiction Treatment 154, pages 209155.
Crossref
Crossref
Carla C. Garcia, Mark Bounthavong, Adam J. Gordon, Allison M. Gustavson, Marie E. Kenny, Wendy Miller, Aryan Esmaeili, Princess E. Ackland, Barbara A. Clothier, Ann Bangerter, Siamak Noorbaloochi, Alex H. S. Harris & Hildi J. Hagedorn. (2023) Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implementation Science Communications 4:1.
Crossref
Crossref
Jane J. Kim, Mohammadali Nikoo, Nooshin Nikoo, Sanam Javidanbardan, Alireza Kazemi, Fiona Choi, Ali Gholami, Neda Y. Lafooraki, Marc Vogel, Pouya Rezazadeh-Azar, Maximilian Meyer, Maurice Cabanis, Kerry Jang, Shahin Aknondzadeh & Michael Krausz. (2023) Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial. Drug and Alcohol Dependence 249, pages 110874.
Crossref
Crossref
Adam J. Gordon, Andrew J. Saxon, Stefan Kertesz, Jessica J. Wyse, Ajay Manhapra, Lewei A. Lin, Wei Chen, Jared Hansen, Derek Pinnell, Tina Huynh, Jacob D. Baylis, Francesca E. Cunningham, Udi E. Ghitza, Gavin Bart, Hong Yu & Brian C. Sauer. (2023) Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence 248, pages 109902.
Crossref
Crossref
Crystal L Smith, Abigail Keever, Theresa Bowden, Katie Olson, Nicole Rodin, Michael G McDonell, John M Roll, Gillian Smoody, Jeff LeBrun, Andre QC Miguel & Sterling M McPherson. (2023) Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability. JMIR Formative Research 7, pages e40437.
Crossref
Crossref
Meagan M. Carr, Jennifer D. Ellis, Karen K. Saules & David M. Ledgerwood. (2023) Childhood Adversity, Addiction Severity, and Comorbidity Among Patients Receiving Opioid Use Disorder Treatment. Journal of Nervous & Mental Disease 211:2, pages 150-156.
Crossref
Crossref
Melexima Simirea, Cédric Baumann, Michael Bisch, Hélène Rousseau, Paolo Di Patrizio, Sarah Viennet & Stéphanie Bourion-Bédès. (2022) Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Kara Zivin, Lindsay Allen, Andrew J. Barnes, Stefanie Junker, Joo Yeon Kim, Lu Tang, Susan Kennedy, Katherine A. Ahrens, Marguerite Burns, Sarah Clark, Evan Cole, Dushka Crane, David Idala, Paul Lanier, Shamis Mohamoud, Marian Jarlenski, Mary Joan McDuffie, Jeffery Talbert, Adam J. Gordon & Julie M. Donohue. (2022) Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN). Medical Care 60:9, pages 680-690.
Crossref
Crossref
Emily Martin, Hayley Maher, Gemma McKeon, Sue Patterson, Julie Blake & Kai Yang Chen. (2022) Long-acting injectable buprenorphine for opioid use disorder: A systematic review of impact of use on social determinants of health. Journal of Substance Abuse Treatment 139, pages 108776.
Crossref
Crossref
Olivia K. Golan, Rachel Totaram, Elizabeth Perry, Kennicia Fortson, Raul Rivera-Atilano, Rebecca Entress, Matthew Golan, Barbara Andraka-Christou, Daniel Whitaker & Therese Pigott. (2022) Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder. Drug and Alcohol Dependence 235, pages 109445.
Crossref
Crossref
Stijn Veldman, Maria van Beek, Steffie van Rijswijk, Hannah Ellerbroek, Hans Timmerman, Selina van der Wal, Monique Steegers & Arnt Schellekens. (2022) Effects of opioid rotation to buprenorphine/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder. Pain 163:5, pages 955-963.
Crossref
Crossref
Bradley D. Stein, Brendan Saloner, Rose Kerber, Mark Sorbero & Adam J. Gordon. (2022) Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020. Annals of Emergency Medicine 79:5, pages 441-450.
Crossref
Crossref
Ashley O. Radmall, Spencer Calder, Nodira Codell, Alan Taylor Kelley, Eric Hawkins, Audrey L. Jones, Hildi J. Hagedorn, Mary Anne Reynolds & Adam J. Gordon. (2022) Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of Addictions Nursing 33:2, pages 70-79.
Crossref
Crossref
Adam J. Gordon, Marie Kenny, Matthew Dungan, Allison M. Gustavson, A. Taylor Kelley, Audrey L. Jones, Eric Hawkins, Joseph W. Frank, Anissa Danner, Joseph Liberto & Hildi Hagedorn. (2022) Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings. The American Journal on Addictions 31:2, pages 152-158.
Crossref
Crossref
Courtney D. Nordeck, Christopher Welsh, Robert P. Schwartz, Shannon Gwin Mitchell, Kevin E. O'Grady & Jan Gryczynski. (2022) Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug and Alcohol Dependence Reports 2, pages 100031.
Crossref
Crossref
Richa Shukla, SujitaKumar Kar, PK Dalal & Amit Arya. (2022) Psychosocial functioning among current noninjecting opioid users: Is there any difference between methadone maintenance treatment and treatment as usual?. Indian Journal of Psychiatry 64:1, pages 56.
Crossref
Crossref
Jeremiah W. Bertz, Kirsten E. Smith, Leigh V. Panlilio, Samuel W. Stull, David Reamer, Marie-Louise Murville, Michael Sullivan, August F. Holtyn, Forrest Toegel, David H. Epstein, Karran A. Phillips & Kenzie L. Preston. (2021) Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work. Drug and Alcohol Dependence Reports 1, pages 100011.
Crossref
Crossref
E. Andrew Townsend, R. Kijoon Kim, Hannah L. Robinson, Samuel A. Marsh, Matthew L. Banks & Peter J. Hamilton. (2021) Opioid Withdrawal Produces Sex-Specific Effects on Fentanyl-Versus-Food Choice and Mesolimbic Transcription. Biological Psychiatry Global Open Science 1:2, pages 112-122.
Crossref
Crossref
Stephanie Paula Elisabeth Guillery, Rainer Hellweg, Golo Kronenberg, Ulrich Bohr, Hagen Kunte & Sören Enge. (2021) Quality of Life in Opioid Replacement Therapy: A Naturalistic Cross-Sectional Comparison of Methadone/Levomethadone, Buprenorphine, and Diamorphine Patients. European Addiction Research 27:5, pages 371-380.
Crossref
Crossref
Cynthia Ann Opie, Penelope Wood, Helen Mary Haines & Richard C. Franklin. (2021) “Here Comes the Junkies,” Opioid Replacement Therapy in Rural Australia. Journal of Addictions Nursing 32:1, pages E1-E10.
Crossref
Crossref
Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Aaron G. Lim, Sabine Ruths, Kamrul Islam, Jan Erik Askildsen, Else-Marie Løberg, Lars Thore Fadnes, Kjell Arne Johansson, Christer Frode Aas, Vibeke Bråthen Buljovcic, Fatemeh Chalabianloo, Jan Tore Daltveit, Silvia Eiken Alpers, Lars T. Fadnes, Trude Fondenes Eriksen, Per Gundersen, Velinda Hille, Kristin Holmelid Håberg, Kjell Arne Johansson, Rafael Alexander Leiva, Siv-Elin Leirvåg Carlsen, Martine Lepsøy Bonnier, Lennart Lorås, Else-Marie Løberg, Mette Hegland Nordbotn, Cathrine Nygård, Maria Olsvold, Christian Ohldieck, Lillian Sivertsen, Hugo Torjussen, Jørn Henrik Vold, Jan-Magnus Økland, Tone Lise Eielsen, Nancy Laura Ortega Maldonado, Ewa Joanna Wilk, Ronny Bjørnestad, Ole Jørgen Lygren, Marianne Cook Pierron, Olav Dalgard, Håvard Midgard, Svetlana Skurtveit & Peter Vickerman. (2020) Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Crossref
Ophélie Müller, Cédric Baumann, Paolo Di Patrizio, Sarah Viennet, Guillaume Vlamynck, Laura Collet, Isabelle Clerc-Urmès, Raymund Schwan & Stéphanie Bourion-Bédès. (2020) Patient’s early satisfaction with care: a predictor of health-related quality of life change among outpatients with substance dependence. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Lia N. Pizzicato, Jeffrey K. Hom, Monica Sun, Caroline C. Johnson & Kendra M. Viner. (2020) Adherence to buprenorphine: An analysis of prescription drug monitoring program data. Drug and Alcohol Dependence 216, pages 108317.
Crossref
Crossref
Lisa Strada, Christiane Sybille Schmidt, Moritz Rosenkranz, Uwe Verthein, Norbert Scherbaum, Jens Reimer & Bernd Schulte. (2019) Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy 14:1.
Crossref
Crossref
Yu-Liang Chen, Tsung-Chieh Lee, Yun-Tai Chen, Lun-Chien Lo, Wen-Yu Hsu & Wen-Chen Ouyang. (2019) Efficacy of Electroacupuncture Combined with Methadone Maintenance Therapy: A Case-Control Study. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-7.
Crossref
Crossref
Adam J. Gordon, Gerald Cochran, Marcela C. Smid, Ajay Manhapra & Stefan G. Kertesz. 2019. Treating Opioid Addiction. Treating Opioid Addiction
223
238
.
Martin Bråbäck, Louise Brådvik, Katja Troberg, Pernilla Isendahl, Suzan Nilsson & Anders Håkansson. (2018) Health Related Quality of Life in Individuals Transferred from a Needle Exchange Program and Starting Opioid Agonist Treatment. Journal of Addiction 2018, pages 1-7.
Crossref
Crossref
Claire B. Simon, Judith I. Tsui, Joseph O. Merrill, Addy Adwell, Elsa Tamru & Jared W. Klein. (2017) Linking patients with buprenorphine treatment in primary care: Predictors of engagement. Drug and Alcohol Dependence 181, pages 58-62.
Crossref
Crossref
Paul Trowbridge, Zoe M. Weinstein, Todd Kerensky, Payel Roy, Danny Regan, Jeffrey H. Samet & Alexander Y. Walley. (2017) Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment. Journal of Substance Abuse Treatment 79, pages 1-5.
Crossref
Crossref
Jeremy W. Bray, Brandon Aden, Ashley A. Eggman, Leah Hellerstein, Eve Wittenberg, Bohdan Nosyk, Judy C. Stribling & Bruce R. Schackman. (2017) Quality of life as an outcome of opioid use disorder treatment: A systematic review. Journal of Substance Abuse Treatment 76, pages 88-93.
Crossref
Crossref
Joni Teoh Bing Fei, Anne Yee, Mohamad Hussain Bin Habil & Mahmoud Danaee. (2016) Effectiveness of Methadone Maintenance Therapy and Improvement in Quality of Life Following a Decade of Implementation. Journal of Substance Abuse Treatment 69, pages 50-56.
Crossref
Crossref
David E. Marcovitz, R. Kathryn McHugh, Julie Volpe, Victoria Votaw & Hilary S. Connery. (2016) Predictors of early dropout in outpatient buprenorphine/naloxone treatment. The American Journal on Addictions 25:6, pages 472-477.
Crossref
Crossref
Emanuel Krebs, Thomas Kerr, Evan Wood & Bohdan Nosyk. (2016) Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder. Journal of Substance Abuse Treatment 67, pages 30-37.
Crossref
Crossref
Jens Reimer, Nat Wright, Lorenzo Somaini, Carlos Roncero, Icro Maremmani, Neil McKeganey, Richard Littlewood, Peter Krajci, Hannu Alho & Oscar D''Agnone. (2016) The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. European Addiction Research 22:2, pages 99-106.
Crossref
Crossref
B. Nosyk, J.W. Bray, E. Wittenberg, B. Aden, A.A. Eggman, R.D. Weiss, J. Potter, A. Ang, Y.-I. Hser, W. Ling & B.R. Schackman. (2015) Short term health-related quality of life improvement during opioid agonist treatment. Drug and Alcohol Dependence 157, pages 121-128.
Crossref
Crossref
Brandon S. Bentzley, Kelly S. Barth, Sudie E. Back, Garrett Aronson & Sarah W. Book. (2015) Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. Journal of Substance Abuse Treatment 56, pages 48-53.
Crossref
Crossref
Brandon S. Bentzley, Kelly S. Barth, Sudie E. Back & Sarah W. Book. (2015) Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes. Journal of Substance Abuse Treatment 52, pages 48-57.
Crossref
Crossref
Stéphanie Bourion-Bédès, Raymund Schwan, Jonathan Epstein, Vincent Laprevote, Alex Bédès, Jean-Louis Bonnet & Cédric Baumann. (2014) Combination of classical test theory (CTT) and item response theory (IRT) analysis to study the psychometric properties of the French version of the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF). Quality of Life Research 24:2, pages 287-293.
Crossref
Crossref
H.-M. Sun, X.-Y. Li, E. P. F. Chow, T. Li, Y. Xian, Y.-H. Lu, T. Tian, X. Zhuang & L. Zhang. (2015) Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open 5:1, pages e005997-e005997.
Crossref
Crossref
David J Nutt. (2014) Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective. Journal of Psychopharmacology 29:1, pages 43-49.
Crossref
Crossref
En-Chi Chiu, I-Ping Hsueh, Cheng-Hsi Hsieh & Ching-Lin Hsieh. (2014) Tests of data quality, scaling assumptions, reliability, and construct validity of the SF-36 health survey in people who abuse heroin. Journal of the Formosan Medical Association 113:4, pages 234-241.
Crossref
Crossref
Agnieszka Kuba, Zbigniew Wawrzyniak & Jadwiga Zalewska-Kaszubska. (2014) Metadonowa terapia substytucyjna w opinii pacjentów programu metadonowego z województwa łódzkiego – skuteczność, korzyści, problemy. Alcoholism and Drug Addiction 27:1, pages 55-65.
Crossref
Crossref
Ying-Chun Chou, Shu-Fang Shih, Wei-Der Tsai, Chiang-shan R Li, Ke Xu & Tony Szu-Hsien Lee. (2013) Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study. BMC Psychiatry 13:1.
Crossref
Crossref
Enisha Sarin, Luke J. Samson & Michael D. Sweat. (2012) Impact of Acts of Discrimination on Quality of Life Among Injecting Drug Users in Delhi, India. Social Indicators Research 113:1, pages 319-334.
Crossref
Crossref
Ramli Musa, Ahmad Zafri Abu Bakar & Umeed Ali Khan. (2011) Two-Year Outcomes of Methadone Maintenance Therapy at a Clinic in Malaysia. Asia Pacific Journal of Public Health 24:5, pages 826-832.
Crossref
Crossref
Dennis W. Raisch, Heather M. Campbell, David A. Garnand, Mark A. Jones, Mike R. Sather, Rupali Naik & Walter Ling. (2011) Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Quality of Life Research 21:7, pages 1177-1183.
Crossref
Crossref
Stephen T. Tiffany, Lawrence Friedman, Shelly F. Greenfield, Deborah S. Hasin & Ron Jackson. (2011) Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction 107:4, pages 709-718.
Crossref
Crossref
Chia-Yu Chen, Shuo-Yen Ting, Happy Kuy-Lok Tan & Ming-Chin Yang. (2012) A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan. Value in Health 15:1, pages S60-S64.
Crossref
Crossref
Bohdan Nosyk, Daphne P. Guh, Huiying Sun, Eugenia Oviedo-Joekes, Suzanne Brissette, David C. Marsh, Martin T. Schechter & Aslam H. Anis. (2011) Health related quality of life trajectories of patients in opioid substitution treatment. Drug and Alcohol Dependence 118:2-3, pages 259-264.
Crossref
Crossref
P Todd Korthuis, Mary Jo Tozzi, Vijay Nandi, David A Fiellin, Linda Weiss, James E Egan, Michael Botsko, Angela Acosta, Marc N Gourevitch, David Hersh, Jeffrey Hsu, Joshua Boverman & Frederick L Altice. (2011) Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:Supplement 1, pages S39-S45.
Crossref
Crossref
A. Karow, J. Reimer, I. Schäfer, M. Krausz, C. Haasen & U. Verthein. (2010) Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Drug and Alcohol Dependence 112:3, pages 209-215.
Crossref
Crossref
Jessica De Maeyer, Wouter Vanderplasschen & Eric Broekaert. (2010) Quality of life among opiate-dependent individuals: A review of the literature. International Journal of Drug Policy 21:5, pages 364-380.
Crossref
Crossref
Dieter Naber, Monika Bullinger & Anne Karow. 2010. Grundlagen der Neuro-Psychopharmakologie. Grundlagen der Neuro-Psychopharmakologie
465
474
.